Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 64


China national lung cancer screening guideline with low-dose computed tomography (2015 version).

Zhou QH, Fan YG, Bu H, Wang Y, Wu N, Huang YC, Wang G, Wang XY, Qiao YL.

Thorac Cancer. 2015 Nov;6(6):812-8. doi: 10.1111/1759-7714.12287. Epub 2015 Aug 4.


An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice.

Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST.


Implementing lung cancer screening in the real world: opportunity, challenges and solutions.

Optican RJ, Chiles C.

Transl Lung Cancer Res. 2015 Aug;4(4):353-64. doi: 10.3978/j.issn.2218-6751.2015.07.14. Review.


Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions.

Weissfeld JL, Lin Y, Lin HM, Kurland BF, Wilson DO, Fuhrman CR, Pennathur A, Romkes M, Nukui T, Yuan JM, Siegfried JM, Diergaarde B.

J Thorac Oncol. 2015 Nov;10(11):1538-45. doi: 10.1097/JTO.0000000000000666.


Mouse double minute-2 homolog (MDM2)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population.

Wang X, Jin L, Cui J, Ma K, Chen X, Li W.

Thorac Cancer. 2015 Jan;6(1):91-6. doi: 10.1111/1759-7714.12153. Epub 2015 Jan 7.


Risk Classification with an Adaptive Naive Bayes Kernel Machine Model.

Minnier J, Yuan M, Liu JS, Cai T.

J Am Stat Assoc. 2015 Apr 22;110(509):393-404.


Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.

Cui JW, Li W, Han FJ, Liu YD.

Transl Lung Cancer Res. 2015 Jun;4(3):275-86. doi: 10.3978/j.issn.2218-6751.2015.02.05. Review.


Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.

Ali N, Lifford KJ, Carter B, McRonald F, Yadegarfar G, Baldwin DR, Weller D, Hansell DM, Duffy SW, Field JK, Brain K.

BMJ Open. 2015 Jul 14;5(7):e008254. doi: 10.1136/bmjopen-2015-008254.


Lung cancer screening: identifying the high risk cohort.

Marcus MW, Raji OY, Field JK.

J Thorac Dis. 2015 Apr;7(Suppl 2):S156-62. doi: 10.3978/j.issn.2072-1439.2015.04.19. Review.


A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor.

Wilson DO, Weissfeld J.

Lung Cancer. 2015 Jul;89(1):31-7. doi: 10.1016/j.lungcan.2015.03.021. Epub 2015 Mar 28.


Clinical characteristics and prognosis of incidentally detected lung cancers.

Quadrelli S, Lyons G, Colt H, Chimondeguy D, Buero A.

Int J Surg Oncol. 2015;2015:287604. doi: 10.1155/2015/287604. Epub 2015 Feb 3.


Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

Tammem├Ągi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD.

PLoS Med. 2014 Dec 2;11(12):e1001764. doi: 10.1371/journal.pmed.1001764. eCollection 2014 Dec. Erratum in: PLoS Med. 2015 Jan;12(1):e1001787.


Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G.

Chest. 2015 Feb;147(2):295-303. doi: 10.1378/chest.14-2500.


What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

O'Dowd EL, McKeever TM, Baldwin DR, Anwar S, Powell HA, Gibson JE, Iyen-Omofoman B, Hubbard RB.

Thorax. 2015 Feb;70(2):161-8. doi: 10.1136/thoraxjnl-2014-205692. Epub 2014 Oct 13.


A review of cancer risk prediction models with genetic variants.

Wang X, Oldani MJ, Zhao X, Huang X, Qian D.

Cancer Inform. 2014 Sep 21;13(Suppl 2):19-28. doi: 10.4137/CIN.S13788. eCollection 2014. Review.


Lung cancer screening: subsequent evidences of national lung screening trial.

Park YS.

Tuberc Respir Dis (Seoul). 2014 Aug;77(2):55-9. doi: 10.4046/trd.2014.77.2.55. Epub 2014 Aug 29. Review.


The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.

El-Zein RA, Lopez MS, D'Amelio AM Jr, Liu M, Munden RF, Christiani D, Su L, Tejera-Alveraz P, Zhai R, Spitz MR, Etzel CJ.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2462-70. doi: 10.1158/1055-9965.EPI-14-0462. Epub 2014 Aug 29.


Predicting lung cancer prior to surgical resection in patients with lung nodules.

Deppen SA, Blume JD, Aldrich MC, Fletcher SA, Massion PP, Walker RC, Chen HC, Speroff T, Degesys CA, Pinkerman R, Lambright ES, Nesbitt JC, Putnam JB Jr, Grogan EL.

J Thorac Oncol. 2014 Oct;9(10):1477-84. doi: 10.1097/JTO.0000000000000287.


Unique volatolomic signatures of TP53 and KRAS in lung cells.

Davies MP, Barash O, Jeries R, Peled N, Ilouze M, Hyde R, Marcus MW, Field JK, Haick H.

Br J Cancer. 2014 Sep 9;111(6):1213-21. doi: 10.1038/bjc.2014.411. Epub 2014 Jul 22.


Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling.

McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ.

PLoS One. 2014 Jun 30;9(6):e99978. doi: 10.1371/journal.pone.0099978. eCollection 2014.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk